Articles
-
Sep 4, 2024 |
clinicalleader.com | Guriqbal Singh |Kamil Shaik
Webinar: Making an Impact on Sustainability Through Vendor Collaboration and Smart Procurement StrategiesWith reports that industries worldwide could save $437 billion per year by 2030 by improving energy efficiency alone, sustainability initiatives are a driving force behind the evolution of business processes and technological development.
-
Jul 17, 2024 |
clinicalleader.com | Guriqbal Singh |Kamil Shaik
By Guriqbal Singh and Kamil Shaik, RegWeb Consulting Services Inc. In the rapidly evolving healthcare sector, where advancements have the potential to revolutionize lives and our comprehension of medicine, the EU has made a significant stride by implementing the Clinical Trial Regulation (EU) 536/2014 (CT Regulation), which replaces the old Clinical Trials Directive 2001/20/EC (CT Directive).
-
Apr 1, 2024 |
outsourcedpharma.com | Kamil Shaik |Guriqbal Singh |Jean-Sebastien Steffen |Ann McMahon |Louis Garguilo
Webinar: De-Risking The Aseptic Drug-Filling Process And Optimizing ProductionIn the aseptic drug-filling process for biotherapeutics, your company may find it challenging to meet regulatory compliance standards, putting the safety and effectiveness of your products at risk. Join us and gain valuable insights into enhancing the efficiency and reliability of the drug product manufacturing process.
-
Mar 15, 2024 |
pharmaceuticalonline.com | Kamil Shaik |Guriqbal Singh |Kurt McCauley
Drug developers aspire to treat patients globally, but navigating diverse regulatory structures around the world gets tricky. These consultants offer a primer on the regulatory bodies of the world. Quality Control In Medical Writing: What It Means And Why It MattersIn effective organizations completing projects smoothly, learn why quality control is not an “I email you a document and you review it” task meant to be completed quickly.
-
Mar 14, 2024 |
biosimilardevelopment.com | Erich Bozenhardt |Kamil Shaik |Guriqbal Singh
Get more biosimilar development insight with our FREE newsletter Newsletter | March 14, 2024 After decades of helping to rescue biotech and pharma companies from environmental monitoring excursions, Herman and Erich Bozenhardt bring this discussion about specific problems you should avoid. A key challenge to better uptake of continuous processes in biologics manufacturing is the necessity to link unit operations.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →